U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
104941104941Clinical Evaluation of Bioadhesive Gels for Oral Cancer ChemopreventionCompletedHas ResultsSquamous Cell Carcinoma of Mouth|Intraepithelial NeoplasiaDrug: 10% FBR containing bioadhesive gel|Drug: placebo gelhttps://ClinicalTrials.gov/show/NCT01192204
104942104942A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPDCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: Fluticasone Furoate/GW642444 Inhalation Powder 100/25mcg|Drug: Fluticasone Furoate/GW642444 Inhalation Powder 200/25mcghttps://ClinicalTrials.gov/show/NCT01192191
104943104943Fall Epidemic Viral Pediatric StudyCompletedHas ResultsAsthmaDrug: FLOVENTâ„¢ DISKUSâ„¢ 100 mcg BID|Drug: ADVAIRâ„¢ DISKUSâ„¢ 100/50 mcg BIDhttps://ClinicalTrials.gov/show/NCT01192178
104944104944Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNo Results AvailableCancerDrug: Trametinib (GSK1120212)|Drug: Docetaxel|Drug: Erlotinib|Drug: Pemetrexed|Drug: Carboplatin|Drug: nab-Paclitaxel|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT01192165
104945104945Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XRCompletedHas ResultsDiabetes MellitusDrug: saxagliptin|Drug: Glucophage XR|Drug: saxagliptin + metformin XR (FDC tablet)https://ClinicalTrials.gov/show/NCT01192152
104946104946Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)CompletedHas ResultsDiabetes MellitusDrug: saxagliptin|Drug: metformin XR|Drug: saxagliptin + metformin XR (FDC tablet)https://ClinicalTrials.gov/show/NCT01192139
104947104947A Study to Evaluate the Product Performance of a Daily Disposable Contact LensCompletedHas ResultsMyopia|Contact LensesDevice: Bausch & Lomb new daily disposable|Device: Johnson & Johnson Acuvue Moisthttps://ClinicalTrials.gov/show/NCT01192126
104948104948Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)CompletedNo Results AvailablePeripheral NeuropathyDrug: Mecobalamin IV Injection|Drug: Mecobalamin IM injection|Drug: Mecobalamin IV or IM injectionhttps://ClinicalTrials.gov/show/NCT01192113
104949104949The Beneficial Effects of a Protein-rich Breakfast on Appetite Control & Cognition in Overweight and Obese AdolescentsCompletedNo Results AvailableOverweight|ObesityOther: Dietary Interventions: Normal protein/protein-rich breakfast mealshttps://ClinicalTrials.gov/show/NCT01192100
104950104950Adenoid Cystic Carcinoma, Erbitux, and Particle TherapyRecruitingNo Results AvailableAdenoid Cystic CarcinomaDrug: Cetuximabhttps://ClinicalTrials.gov/show/NCT01192087
104951104951Use of Ultrasound in Obstetric Neuraxial Analgesia and Anesthesia Data BaseRecruitingNo Results AvailablePregnancyDevice: Ultrasoundhttps://ClinicalTrials.gov/show/NCT01192074
104952104952Autonomic Nervous System Activity and Normal Tension GlaucomaCompletedNo Results AvailableNormal Tension Glaucomahttps://ClinicalTrials.gov/show/NCT01192061
104953104953Genetics of Congenital Heart DiseaseRecruitingNo Results AvailableCongenital Heart DiseaseOther: Blood Sample Collectionhttps://ClinicalTrials.gov/show/NCT01192048
104954104954PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA TrialCompletedNo Results AvailableHIV-1Drug: Efavirenz or Nevirapine|Drug: Ritonavir-boosted lopinavirhttps://ClinicalTrials.gov/show/NCT01192035
104955104955TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection SurgeryCompletedNo Results AvailableHemorrhageBiological: secondary hemostatic treatment|Device: Surgicel® Originalhttps://ClinicalTrials.gov/show/NCT01192022
104956104956Leucine Supplementation and Skeletal Muscle DisuseCompletedNo Results AvailableDisuse AtrophyDietary Supplement: Leucine|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01192009
104957104957Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple SclerosisCompletedNo Results AvailableSecondary Progressive Multiple Sclerosis|Primary Progressive Multiple SclerosisBiological: MIS416https://ClinicalTrials.gov/show/NCT01191996
104958104958A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic NephropathyRecruitingNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT01191983
104959104959Epidural Analgesia, Beta-Endorphin Concentrations in Colostrum, and Infant Neurobehavior as Breast-Feeding PredictorsNot yet recruitingNo Results AvailableBreastfeeding|Lactation|Analgesiahttps://ClinicalTrials.gov/show/NCT01191970
104960104960Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AMLCompletedNo Results AvailableAcute Myeloid Leukemia (AML)Drug: Busulphan plus Cyclophosphamide|Drug: Busulphan plus Fludarabinehttps://ClinicalTrials.gov/show/NCT01191957
104961104961Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) PatientsCompletedHas ResultsParkinson DiseaseDrug: pramipexole immediate release tablet|Drug: pramipexole extended release tablethttps://ClinicalTrials.gov/show/NCT01191944
104962104962Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)CompletedNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT01191931
104963104963The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute ManiaCompletedNo Results AvailableBipolar Disorder|ManiaDrug: Donepezil and Lithium|Drug: Placebo plus Lithiumhttps://ClinicalTrials.gov/show/NCT01191918
104964104964Effects of HIgh Volume COntinuous REnal Replacement Therapy in Patients With Septic Acute Kidney InjuryCompletedNo Results AvailableSepsis|Kidney Failure, Acute|Renal Replacement TherapyDrug: high dose CRRT|Drug: Conventional dose CRRThttps://ClinicalTrials.gov/show/NCT01191905
104965104965Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerRecruitingNo Results AvailableBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Ureter Cancer|Urethral CancerDrug: carboplatin|Drug: gemcitabine hydrochloride|Drug: vandetanib|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01191892
104966104966A Comparison of p53-induced Genes Activation in Patients With and Without Acute Myocardial InfarctionCompletedNo Results AvailableAcute Myocardial InfarctionOther: Blood testhttps://ClinicalTrials.gov/show/NCT01191879
104967104967Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes MellitusRecruitingNo Results AvailableDiabetes MellitusBehavioral: psychosocial interventionhttps://ClinicalTrials.gov/show/NCT01191866
104968104968Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza VaccinesCompletedNo Results AvailableHealthy Volunteershttps://ClinicalTrials.gov/show/NCT01191853
104969104969Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream InfectionRecruitingNo Results AvailableBacteremiaDrug: Vancomycin|Drug: Vancomycinhttps://ClinicalTrials.gov/show/NCT01191840
104970104970fMRI Cholinergic Mechanisms in SchizophreniaCompletedHas ResultsSchizophreniahttps://ClinicalTrials.gov/show/NCT01191827

* Görseller ve İçerik tekif hakkına sahip olabilir